Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/300119 stock hub

SHE/300119 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300119is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

8.1B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300119

In the news

Latest news · SHE/300119

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19.6

P25 17.1P50 24.2P75 37.8

Trailing P/E20.8

P25 23.5P50 41.3P75 83.2

ROE8.3

P25 -0.9P50 4.1P75 8.8

ROIC7

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300119 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

241

Groups with data

Currency

CNY

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	2,803
Employees Change	-97%
Employees Change Percent	-3.34
Enterprise value	CNY 8.4B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100000TV1
Last refreshed	2026-05-10
Market cap	CNY 8.1B
Price	CNY 17.93
Price currency	CNY
Rev Per Employee	1,214,044.97x
Sector	Healthcare
Sic	2836
Symbol	she/300119
Website	https://www.ringpu.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.82%
EV Earnings	21.53x
EV/EBIT	22.48x
EV/EBITDA	14.04x
EV/FCF	115.77x
EV/Sales	2.48x
FCF yield	0.9%
Forward P/E	19.56x
P/B ratio	1.54x
P/E ratio	20.75x
P/S ratio	2.39x
PE Ratio10 Y	29.78x
PE Ratio3 Y	20.44x
PE Ratio5 Y	22.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.04%
EBITDA Margin	17.35%
FCF margin	2.14%
Gross margin	40.68%
Gross Profit	CNY 1.4B
Gross Profit Growth	5.7%
Gross Profit Growth Q	-3.1%
Gross Profit Growth3 Y	9.92%
Gross Profit Growth5 Y	4.27%
Net Income	CNY 392.3M
Net Income Growth	20.19%
Net Income Growth Q	-7.08%
Net Income Growth Years	1%
Net Income Growth3 Y	3.36%
Net Income Growth5 Y	-2.33%
Pretax Margin	13.63%
Profit Margin	11.53%
Profit Per Employee	CNY 139,960
Profitable Years	19
ROA	2.96
Roa5y	3.63
ROCE	6.43
ROE	8.34
Roe5y	9.35
ROIC	6.95
Roic5y	9.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	2.68%
Cagr15y	5.75%
Cagr1y	-9.48%
Cagr3y	-3.92%
Cagr5y	-8.01%
Div CAGR10	10.31%
Div CAGR3	10.06%
Div CAGR5	0%
EPS Growth	21.46
EPS Growth Q	-6.87
EPS Growth Years	1
EPS Growth3 Y	4.07
EPS Growth5 Y	-4.94
FCF Growth	-86.07%
FCF Growth3 Y	-19.42%
FCF Growth5 Y	-11.43%
OCF Growth	-67.24%
OCF Growth Q	-84.57%
OCF Growth10 Y	0.56%
OCF Growth3 Y	-20.77%
OCF Growth5 Y	-11.7%
Revenue Growth	6.11x
Revenue Growth Q	0.55x
Revenue Growth Quarters	1x
Revenue Growth Years	11x
Revenue Growth3 Y	16.79x
Revenue Growth5 Y	10.07x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.43
Assets	CNY 7.8B
Cash	CNY 1.7B
Current Assets	CNY 3.5B
Current Liabilities	CNY 2B
Debt	CNY 1.5B
Debt EBITDA	CNY 2.54
Debt Equity	CNY 0.29
Debt FCF	CNY 20.93
Equity	CNY 5.3B
Interest Coverage	10.69
Liabilities	CNY 2.5B
Long Term Assets	CNY 4.3B
Long Term Liabilities	CNY 572.3M
Net Cash	CNY 154.1M
Net Cash By Market Cap	CNY 1.89
Net Cash Growth	-67.55%
Net Debt EBITDA	CNY -0.26
Net Debt Equity	CNY -0.03
Net Debt FCF	CNY -2.11
Tangible Book Value	CNY 3.9B
Tangible Book Value Per Share	CNY 8.58
WACC	5.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.81
Inventory Turnover	3.91
Net Working Capital	CNY 1.1B
Quick ratio	1.48
Working Capital	CNY 1.6B
Working Capital Turnover	CNY 2.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.05%
Dividend Growth	33.33%
Dividend Growth Years	0%
Dividend per share	CNY 0.4
Dividend Years	16
Dividend Yield	2.23%
Ex Div Date	2026-05-13
Last Dividend	CNY 0.4
Payout Frequency	Annual
Payout Ratio	42.71%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	30.26%
1Y total return	-9.47%
200-day SMA	20.2
3Y total return	-11.31%
50-day SMA	18.56
50-day SMA vs 200-day SMA	50under200
5Y total return	-34.12%
All Time High	44.41
All Time High Change	-59.63%
All Time High Date	2021-06-08
All Time Low	6.3
All Time Low Change	184.6%
All Time Low Date	2018-10-19
ATR	0.48
Beta	0.34
Beta1y	0.54
Beta2y	0.47
Ch YTD	-4.48
High	17.98
High52	28.9
High52 Date	2025-05-20
High52ch	-37.96%
Low	17.8
Low52	17.02
Low52 Date	2026-03-23
Low52ch	5.35%
Ma50ch	-3.39%
Price vs 200-day SMA	-11.23%
RSI	44.66
RSI Monthly	47.5
RSI Weekly	41.18
Sharpe ratio	0.2x
Sortino ratio	0.44
Total Return	3.28%
Tr YTD	-4.48
Tr15y	131.42%
Tr1m	-5.03%
Tr1w	0.34%
Tr3m	-6.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 375.8M
Operating Income Growth	-8.17
Operating Income Growth Q	13.96
Operating Income Growth3 Y	1.3
Operating Income Growth5 Y	-3.08
Operating margin	11.04

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	233,174,383%
Net Borrowing	123,583,282
Shares Insiders	48.65%
Shares Institutions	11.05%
Shares Out	454,067,347
Shares Qo Q	-0%
Shares Yo Y	-1.05%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 73M
Average Volume	4,781,372x
Bv Per Share	10.6
CAPEX	CNY -162.4M
Ch10y	12.63
Ch15y	92.24
Ch1m	-5.03
Ch1w	0.34
Ch1y	-10.48
Ch3m	-6.52
Ch3y	-15.82
Ch5y	-38.78
Ch6m	-12.66
Change	0.28%
Change From Open	0.28
Close	17.88
Days Gap	0
Depreciation Amortization	214,599,069
Dollar Volume	55,475,617.2
Earnings Date	2026-08-25
EBIT	CNY 375.8M
EBITDA	CNY 590.4M
EPS	CNY 0.86
F Score	5
FCF	CNY 73M
FCF EV Yield	0.86x
FCF Per Share	CNY 0.16
Financing CF	-186,929,574
Fiscal Year End	December
Founded	1,998
Goodwill	442,989,818
Graham Number	14.3521
Graham Upside	-19.95
Income Tax	CNY 31.9M
Investing CF	43,811,113
Is Primary Listing	1
Last Earnings Date	2026-03-31
Last Report Date	2026-03-31
Last Split Date	2014-04-22
Last Split Type	Forward
Lynch Fair Value	CNY 4.32
Lynch Upside	-75.91
Ma150	19.68
Ma150ch	-8.9%
Ma20	18.27
Ma20ch	-1.88%
Net CF	91,550,866
Next Earnings Date	2026-08-25
Open	17.88
P FCF Ratio	111.6
P OCF Ratio	34.59
Payment Date	2026-05-13
Position In Range	72.22
Ppne	1,653,787,044
Price Date	2026-05-08
Price EBITDA	CNY 13.79
Ptbv Ratio	2.09
Relative Volume	0.58x
Revenue	3,402,968,051x
Tax By Revenue	0.94x
Tax Rate	6.89%
Tr6m	-12.66%
Volume	3,094,011

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300119 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.2%

$0.40 annual per share

Payout ratio

+42.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

0 consecutive years of growth

Total shareholder yield

+3.3%

Next ex-dividend date: 2026-05-13

Performance

SHE/300119 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300119?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.1%

Share of float held by funds and institutions

Insider ownership

+48.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.0%

Negative means the company is buying back shares.

Technical

SHE/300119 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.7

Neutral momentum band

Price vs 200-day MA

-11.2%

50/200-day relationship not available

Beta (5Y)

0.34

Less volatile than the market

Sharpe ratio

0.20

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300119

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300119 stock rating?

she/300119 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300119 analysis?

The full report lives at /stocks/she/300119/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300119?

The latest report frames she/300119 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300119 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.